Search results
- 2.2199Add to watchlist+0.0599 (+2.77%)As of Mon. Jun 3, 2024 1:44 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open2.1500High2.2400Low2.0800
- Mkt Cap138.86MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close2.160052 Wk. Low1.050052 Wk. High4.1900
Related stocks
Learn why Corvus Pharmaceuticals, Inc. (CRVS) is a Zacks Rank 2 (Buy) stock and get the latest news, quote and history on Yahoo Finance.
Get the latest Corvus Pharmaceuticals Inc (CRVS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief business officer, will conduct one-on-one meetings with investors and present a corporate ...
Apr 22, 2024 · 0.98%. $178.46M. CRVS | Complete Corvus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
- 19.47%
- 12.57%
- 34.62%
- 13.07%
A high-level overview of Corvus Pharmaceuticals, Inc. (CRVS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Elutia Inc.
- Biotechnology
- 54
- 70.88M
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China. (GlobeNewswire) Jan-01-22 07:43AM. Insiders who bought stock earlier this year lose -US$118k as Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) drops to US$112m. (Simply Wall St.)
People also ask
What is Corvus Pharmaceuticals (CRVS) stock price?
Is CRVS (CRVS) a good stock to buy?
Does CRVS pay a dividend?
What does CRVS stand for?
View the latest Corvus Pharmaceuticals Inc. (CRVS) stock price, news, historical charts, analyst ratings and financial information from WSJ.